Beijing's global pharmaceutical push follows same playbook as rare earths, semiconductors and electric vehicles, warn US ...

Oil price spikes aren't the only impact of the ongoing Middle East conflict on the global economy. Here are three other major ...

AI is rewriting drug discovery. Recursion Pharmaceuticals and Tempus AI might be the platforms that turn early investors into millionaires.

Novartis, an innovative medicines company based in Basel, Switzerland, will continue to boost its multidimensional investment strategy in China, by expanding innovation, building manufacturing ...

The escalating war in the Middle East so far has not appreciably disrupted global pharmaceutical supply chains, but it could eventually — affecting prices.

The Motley Fool reports that biotech stocks surged in 2025, driven by FDA approvals and a doubling of longevity investment to ...

Researchers use a novel process involving engineered Escherichia coli to turn plastic waste into levodopa, a frontline ...

For STEM students considering career paths, the PA, NJ, & DE region is recognized as one of the leading biotechnology & ...

Prime biotech buyout targets such as Revolution Medicines and Ascendis Pharma have recently found themselves in the middle of acquisition rumors—though no deals have panned out so far.

Why price, manufacturing and innovation are so intertwined for pharma. Europe’s pharmaceutical industry needs to m ...

Joining the session is Dr. Collin Hovinga, Senior Vice President of Rare and Orphan Disease Programs at C-Path, underscoring the importance of regulatory science tools and qualification of Clinical ...

A new bill introduced in the Maryland House of Delegates requests that pharmas be more specific about the brands related to ...